Âé¶¹´«Ã½

The selected channel has been deleted from your list of favorites.

Our Âé¶¹´«Ã½ on Âé¶¹´«Ã½

Moffitt Study Uncovers a Way to Boost Treatment for Aggressive Melanoma

A new study from researchers at Moffitt Cancer Center shows that blocking a chemical process called nitrosylation could make one of the most aggressive forms of melanoma more treatable.
27-Apr-2025 1:40 PM EDT Add to Favorites

This news release is embargoed

Moffitt Cancer Center Launches New Podcast, The ImmunoVerse, hosted by CEO Dr. Patrick Hwu

Moffitt Cancer Center has launched The ImmunoVerse, a new podcast hosted by President and CEO Patrick Hwu, M.D. A world-renowned physician-scientist and tumor immunologist, Hwu will bring immunotherapy discoveries to life through the voices of those...
21-Apr-2025 6:35 PM EDT Add to Favorites

Âé¶¹´«Ã½: 680660bde7637_SchellMichael.jpg

Michael J. Schell, Ph.D. Elected Fellow of the American Statistical Association

Michael J. Schell, Ph.D., interim chief in the Quantitative Science Division at Moffitt Cancer Center, has been elected a Fellow of the American Statistical Association (ASA), the world’s largest community of statisticians and data scientists....
21-Apr-2025 5:25 PM EDT Add to Favorites

Moffitt Cancer Center Researchers Present Top Science at AACR Annual Meeting 2025

Researchers from Moffitt Cancer Center will present data on the latest advances in cancer science and medicine at the American Association for Cancer Research (AACR) Annual Meeting 2025, which will take place April 25-30 in Chicago. Follow us...
21-Apr-2025 9:00 AM EDT Add to Favorites

Moffitt Study Shows New Immune Boost Could Expand Access to Cancer Immunotherapy

Researchers at Moffitt Cancer Center have found that tapping into the body’s own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of tumor-infiltrating lymphocyte, or TIL therapy....
11-Apr-2025 10:15 AM EDT Add to Favorites

Moffitt-Led International Study Finds New Drug Delivery System Effective Against Rare Eye Cancer

A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that has spread to their liver. This disease, known as metastatic...
10-Apr-2025 8:20 PM EDT Add to Favorites

Moffitt Study Finds Vaccine May Improve Breast Cancer Treatment Outcomes

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen receptor-negative...
18-Mar-2025 8:25 PM EDT Add to Favorites

Moffitt Study Finds New Immunotherapy Strategy for Enhancing Melanoma Treatment

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO.
13-Mar-2025 8:30 PM EDT Add to Favorites


See All News

Our Experts on News

Âé¶¹´«Ã½: AnnaGiuliano_Euroginopeningtalk_2017.jpg

Moffitt Cancer Center HPV Expert Kicked Off EUROGIN Conference

Anna Giuliano, Ph.D., director of Moffitt Cancer Center’s Center for Infection Research in Cancer, delivered the opening keynote address at the 2017 European Research Organization on Genital Infection and Neoplasia (EUROGIN) International...
10-Oct-2017 10:05 AM EDT

See All Experts

Our YouTube Videos

About

Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 56 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 8,500 team members, Moffitt has an economic impact in the state of $2.4 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter, Instagram and YouTube.

Experts

Our Multimedia on News

Twitter

Instagram

Facebook

close
0.28309